This inventor holds 2 USPTO granted patents. Top assignee: Novartis Corporation. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: The Innovations of Irene Püttner
Introduction
Irene Püttner is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the study of human metabotropic glutamate receptors. With a total of 2 patents, her work has implications for understanding various neurological conditions.
Latest Patents
Irene's latest patents include groundbreaking research on human metabotropic glutamate receptor 7 subtypes. This invention relates to human metabotropic glutamate receptor (hmGluR) proteins, isolated nucleic acids coding therefor, host cells producing the proteins of the invention, methods for the preparation of such proteins, nucleic acids and host cells, and uses thereof. Another significant patent focuses on human metabotropic glutamate receptor subtypes (hmR4, hmR6, hmR7) and related DNA compounds, which also involves similar methodologies and applications.
Career Highlights
Irene Püttner is currently associated with Novartis Corporation, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field, enhancing the impact of her research.
Collaborations
Some of her notable coworkers include Rainer Kuhn and Peter Josef Flor, who have contributed to her research endeavors.
Conclusion
Irene Püttner's innovative work in the field of biotechnology exemplifies the importance of research in understanding complex biological systems. Her patents reflect her commitment to advancing scientific knowledge and improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile